Eckert & Ziegler SE (EUZ)

Add to research

Evaluation: Based on all recent filings, financial statements, and news.

See full evaluation
Company performance
Add to research

Current Price

as of Feb 17, 2025

$62.74

P/E Ratio

38.65

Market Cap

$1.3B

Description
Add to research

Eckert & Ziegler SE is a holding company, which engages in the processing of radio isotopes. It also focuses on the development, production, and sale of isotope technology components and related products. It operates through the following segments: Isotope Products, Medical, and Other. The Isotope Products segment manufactures and distributes standards, and radiation sources for medical and industrial purposes. The Medical segment offers small radioactive implants for treating prostate cancer and eye applications for treating uveal melanoma. The Other segment focuses pools internal group services like radiation protection, legal, accounting, information technology, and human resources. The company was founded by Andreas Eckert in 1997 and is headquartered in Berlin, Germany.

Metrics
Add to research

Overview

  • HQBerlin, BE
  • SectorHealth Technology
  • IndustryMedical Specialties
  • TickerEUZ
  • Price$62.735454+0.29%

Trading Information

  • Market cap$1.30B
  • Float67.24%
  • Average Daily Volume (1m)77,378
  • Average Daily Volume (3m)63,560
  • EPS$1.56

Company

  • Revenue$295.00M
  • Rev growth (1yr)19.87%
  • Net income$33.00M
  • Gross marginN/A
  • EBITDA marginN/A
  • EBITDAN/A
  • EVN/A
  • EV/RevenueN/A
  • P/E38.65
  • P/S4.26
  • P/B5.06
  • Debt/EquityN/A
Documents
Add to research